96 related articles for article (PubMed ID: 11460469)
1. Structure and properties of clots from fibrinogen Bicêtre II (gamma 308 Asn-->Lys). Increased permeability due to larger pores, thicker fibers, and decreased rigidity.
Marchi R; Loyau S; Anglés-Cano E; Weisel JW
Ann N Y Acad Sci; 2001; 936():125-8. PubMed ID: 11460469
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA).
Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW
Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Caracas I: a dysfibrinogenemia with a hemorrhagic diathesis associated with diminished fibrin fiber diameter and reduced fibrin gel porosity.
Marchi R; Lundberg U; de Bosch NB; Arocha-Piñango CL
Blood Coagul Fibrinolysis; 1998 Nov; 9(8):733-9. PubMed ID: 9890716
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot.
Marchi RC; Meyer MH; de Bosch NB; Arocha-Piñango CL; Weisel JW
Blood Coagul Fibrinolysis; 2004 Oct; 15(7):559-67. PubMed ID: 15389122
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots.
Collet JP; Woodhead JL; Soria J; Soria C; Mirshahi M; Caen JP; Weisel JW
Biophys J; 1996 Jan; 70(1):500-10. PubMed ID: 8770228
[TBL] [Abstract][Full Text] [Related]
8. Biophysical characterization of fibrinogen Caracas I with an Aalpha-chain truncation at Aalpha-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen.
Marchi R; Meyer M; de Bosch N; Soria J; Arocha-Piñango CL; Weisel JW
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):285-93. PubMed ID: 15166913
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
[TBL] [Abstract][Full Text] [Related]
10. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
Terasawa F; Kani S; Hongo M; Okumura N
Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
Undas A; Zdziarska J; Iwaniec T; Stepien E; Skotnicki AB; de Moerloose P; Neerman-Arbez M
Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553
[No Abstract] [Full Text] [Related]
12. The ultrastructure of fibrinogen Caracas II molecules, fibers, and clots.
Woodhead JL; Nagaswami C; Matsuda M; Arocha-Piñango CL; Weisel JW
J Biol Chem; 1996 Mar; 271(9):4946-53. PubMed ID: 8617768
[TBL] [Abstract][Full Text] [Related]
13. Gene analyses of abnormal fibrinogens with a mutation in the gamma chain.
Mimuro J; Muramatsu S; Maekawa H; Sakata Y; Kaneko M; Yoshitake S; Okuma M; Ito Y; Takeda Y; Matsuda M
Int J Hematol; 1992 Oct; 56(2):129-34. PubMed ID: 1421174
[TBL] [Abstract][Full Text] [Related]
14. The effects of additional carbohydrate in the coiled-coil region of fibrinogen on polymerization and clot structure and properties: characterization of the homozygous and heterozygous forms of fibrinogen Lima (Aalpha Arg141-->Ser with extra glycosylation).
Marchi R; Arocha-Piñango CL; Nagy H; Matsuda M; Weisel JW
J Thromb Haemost; 2004 Jun; 2(6):940-8. PubMed ID: 15140130
[TBL] [Abstract][Full Text] [Related]
15. Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system.
Ajjan RA; Standeven KF; Khanbhai M; Phoenix F; Gersh KC; Weisel JW; Kearney MT; Ariëns RA; Grant PJ
Arterioscler Thromb Vasc Biol; 2009 May; 29(5):712-7. PubMed ID: 19286636
[TBL] [Abstract][Full Text] [Related]
16. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
[TBL] [Abstract][Full Text] [Related]
17. Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.
Brennan SO; Davis RL
Thromb Haemost; 2010 Dec; 104(6):1274-6. PubMed ID: 20838743
[No Abstract] [Full Text] [Related]
18. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.
Allan P; Uitte de Willige S; Abou-Saleh RH; Connell SD; Ariëns RA
J Thromb Haemost; 2012 Jun; 10(6):1072-80. PubMed ID: 22463367
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.
Lounes KC; Lefkowitz JB; Coates AI; Hantgan RR; Henschen-Edman A; Lord ST
Ann N Y Acad Sci; 2001; 936():129-32. PubMed ID: 11460470
[TBL] [Abstract][Full Text] [Related]
20. [Functional analysis of heterozygous plasma dysfibrinogens derived from two families of gammaArg275Cys and three families of gammaArg275His, and haplotype analysis for these families].
Kamijyo Y; Hirota-Kawadobora M; Fujihara N; Wakabayashi S; Matsuda K; Yamauchi K; Terasawa F; Okumura N; Honda T
Rinsho Byori; 2009 Jul; 57(7):651-8. PubMed ID: 19708534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
